Increased iron stores influence glucose metabolism in sickle cell anaemia
1. Spaulding TP, Stockton SS, Savona MR. The evolving role of next generation sequencing in myelodysplastic syndromes. Br J Haematol. 2020;188:224 39. 2. Thol F, Gabdoulline R, Liebich A, Klement P, Schiller J, Kandziora C, et al. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML. Blood. 2018;132:1703 13. 3. Palomo L, Ib a~ nez M, Ab aigar M, V azquez I, Alvarez S, Cabez on T V, et al. Spanish guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2020;188:605 22. 4. Nemoto M, Hattori H, Maeda N, Akita N, Muramatsu H, Moritani S, et al. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T cell lymphopenia. Sci Rep. 2018;8:1 13. 5. Leitner NR, Witalisz Siepracka A, Strobl B, MEUR uller M. Tyrosine kinase 2 surveillant of tumours and bona fide oncogene. Cytokine. 2017;89:209 18. 6. Abul i A, Boada M, Rodr iguez Santiago B, Coroleu B, Veiga A, Armengol L, et al. NGS based assay for the identification of individuals carrying recessive genetic mutations in reproductive medicine. Hum Mutat. 2016;37(6):516 23. 7. Northrup V, Maybank A, Carson N, Rahmeh T. The value of next generation sequencing in the screening and evaluation of hematologic neoplasms in clinical practice. Am J Clin Pathol. 2019 [Epub ahead of print] DOI: 10.1093/ajcp/aqz203.
British journal of haematology